| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa48a431ce250933eb0fdd7a1caf3f30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-703 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-721
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-726
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
| filingDate |
2001-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4f1544f3624af3242209fc2ce524dec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d492934a83dbf376f327c1301c72f5eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d193fa34cda176bb563e7bd086df98e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cc424907bf8153c3460668697e6da50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d40265b5e9f27fe0c37afb00f06ec82 |
| publicationDate |
2002-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0219985-A2 |
| titleOfInvention |
Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure |
| abstract |
This invention relates to a method for inhibiting a decrease in the transdermal flux of an agent that is being transdermally delivered or sampled over a prolonged period of time wherein the delivery or sampling involves disrupting at least the stratum corneum layer of the skin to form pathways through which the agent passes. The desired result is achieved by co-delivering or co-sampling the agent with an amount of at least one anti-healing agent wherein the amount of the anti-healing agent is effective in inhibiting a decrease in the agent transdermal flux compared to when the delivery or sampling of the agent is done under substantially identical conditions except in the absence of the anti-healing agent(s). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014207033-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9987361-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1682012-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1682012-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007511508-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102017126501-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007527392-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019092257-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8920817-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006020841-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006020841-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1734993-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2818159-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1734993-A4 |
| priorityDate |
2000-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |